All News #Library
Rare Diseases
Alterity Reveals Positive ATH434 Ph 2 Trial Results At Congress
09 Oct 2025 //
GLOBENEWSWIRE
Alterity Therapeutics Granted FDA Fast Track for ATH434 for MSA
05 May 2025 //
GLOBENEWSWIRE
Alterity Shows ATH434 Potential in Friedreich`s Ataxia
29 Apr 2024 //
GLOBENEWSWIRE
Alterity Therapeutics Presents New Data at World Orphan Drug Congress
10 Apr 2024 //
GLOBENEWSWIRE
Alterity Therapeutics to Present in MST Access Rare Diseases, Rich Returns
21 Jun 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support